Compare Redwire Corporation (RDW) vs Revvity Inc (RVTY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Redwire Corporation vs Revvity Inc — how do they compare? Redwire Corporation trades at $9.57 (market cap $2.44B), while Revvity Inc trades at $154.1 (market cap $16.98B). The key difference: Revvity Inc is far larger — about 7× Redwire Corporation's market cap, and Revvity Inc pays a 0.18% dividend while Redwire Corporation pays none. Which is the better fit depends on your goals — on Pluang, investors hold Redwire Corporation for 18 Days and Revvity Inc for 12 Days on average.
| RDW | RVTY | |
|---|---|---|
Market Cap | $2.44B | $16.98B |
Volume | 11,053,212 | 1,456,900 |
Sector | Industrials | Health |
52-Week High | $25.90 | $157.36 |
52-Week Low | $5.06 | $82.26 |
Typical Hold Time | 18 Days | 12 Days |
Enterprise Value | $1.97B | $19.30B |
Dividend Yield | — | 0.18% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
RDW trades at $9.58, down 6.45% today, with technical indicators showing bearish momentum despite oversold RSI readings near 27. The company reported significant losses with a -57.26% net income margin and negative cash flow from operations, though revenue grew to $335M in 2025. Recent Space Force contract wins and partnerships highlight growth potential in defense and space infrastructure markets.
While analyst consensus remains bullish with an 80% buy rating and $14.88 price target, RDW faces substantial execution risks from persistent losses and dependence on SpaceX's Starship success. The stock offers high-risk exposure to the growing space economy but requires careful monitoring of profitability improvements and contract execution.
RVTY trades at $155.01, up 0.92% with a bullish technical outlook. The stock shows strong earnings momentum with three consecutive quarterly beats and maintains solid profitability with 54.98% gross margins. Recent developments include new product launches in Europe and strategic acquisitions to expand metabolic disease research capabilities.
The investment case balances premium valuation (P/E 73.15) against consistent execution and growth initiatives. Key risks include China market pressures and margin compression, while analyst consensus remains positive with 52% buy ratings. Upside potential exists if Q3 earnings meet expectations in November.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Redwire Corporation
Redwire Corporation is a pure-play space infrastructure company that provides a wide range of advanced solutions for the next generation of space exploration and utilization. The company's capabilities span critical space technology, including on-orbit servicing, satellite components, space robotics, and digital engineering. Redwire's products and services are used by civil, commercial, and national security customers to enable missions from low Earth orbit to deep space.
Read more on RDW →About Revvity Inc
Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →
